MYRIAD GENETICS INC's ticker is MYGN and the CUSIP is 62855J104. A total of 215 filers reported holding MYRIAD GENETICS INC in Q3 2021. The put-call ratio across all filers is 0.55 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $232 | -31.0% | 14,488 | 0.0% | 0.00% | -50.0% |
| Q2 2023 | $336 | -0.3% | 14,488 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $337 | +60.5% | 14,488 | 0.0% | 0.00% | +100.0% |
| Q4 2022 | $210 | -99.9% | 14,488 | 0.0% | 0.00% | -50.0% |
| Q3 2022 | $276,000 | +4.9% | 14,488 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $263,000 | -27.9% | 14,488 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $365,000 | -26.9% | 14,488 | -19.9% | 0.00% | 0.0% |
| Q4 2021 | $499,000 | -18.2% | 18,088 | -4.2% | 0.00% | -33.3% |
| Q3 2021 | $610,000 | +5.5% | 18,888 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $578,000 | +58.4% | 18,888 | +57.6% | 0.00% | +50.0% |
| Q1 2021 | $365,000 | +54.0% | 11,988 | 0.0% | 0.00% | +100.0% |
| Q4 2020 | $237,000 | +51.9% | 11,988 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $156,000 | -42.6% | 11,988 | -50.0% | 0.00% | 0.0% |
| Q2 2020 | $272,000 | – | 23,976 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tieton Capital Management, LLC | 160,434 | $4,457,000 | 3.90% |
| KESTREL INVESTMENT MANAGEMENT CORP | 231,875 | $6,441,000 | 3.04% |
| SG Capital Management LLC | 501,818 | $13,941,000 | 2.21% |
| DISCIPLINED GROWTH INVESTORS INC /MN | 2,707,364 | $75,211,000 | 1.40% |
| Global Alpha Capital Management Ltd. | 269,000 | $7,473,000 | 1.30% |
| S&T BANK/PA | 166,772 | $4,633,000 | 1.02% |
| MARATHON CAPITAL MANAGEMENT | 79,460 | $2,207,000 | 0.90% |
| Taylor Frigon Capital Management LLC | 45,903 | $1,275,000 | 0.88% |
| PURA VIDA INVESTMENTS, LLC | 200,000 | $5,556,000 | 0.84% |
| Millrace Asset Group, Inc. | 29,222 | $812,000 | 0.84% |